Technology
Health
Pharmaceutical
Liquidia Technologies
$7.619876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.24 (-3.01%) As of 1:58 PM EDT today
-$0.24 (-3.01%) Today
Why Robinhood?
You can buy or sell LQDA and other stocks, options, ETFs, and crypto commission-free!
About LQDA
Liquidia Technologies, Inc. Common Stock, also called Liquidia Technologies, is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. Read More It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded in 2004 and is headquartered in Durham, NC.
Employees
63
Headquarters
Morrisville, North Carolina
Founded
2004
Market Cap
146.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
82.19K
High Today
$8.03
Low Today
$7.48
Open Price
$7.80
Volume
66.58K
52 Week High
$38.46
52 Week Low
$7.21
Collections
Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Therapy
2018 IPO
US
Price Paid on Robinhood
37% Lower
Right Now
52 Week Low
$7.21
Average Price Paid
$12.02
52 Week High
$38.46
LQDA Earnings
-$0.87
-$0.77
-$0.67
-$0.57
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, Pre-Market